ZD12

N/A

Report date: 2023/05/15 17:48:41
NME

Base Information

Drug NameZD12
Drug Alias NameZD-12ZD12
ClassificationSmall molecules > Proteolysis-Targeting Chimera (PROTAC)
Mechanisms of ActionEstrogen receptor alpha degraders
TargetsEstrogen receptor alpha
Therapy Area/IndicationsHR-positive breast cancer
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesWuhan University
China Registration ClassN/A

Develop Information

Active CompaniesWuhan University
Inactive CompaniesN/A
Active IndicationsHR-positive breast cancer
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A